Daly AK - Search Results

1

A genetic risk score and diabetes predict development of alcohol-related cirrhosis in drinkers.

Whitfield JB, Schwantes-An TH, Darlay R, Aithal GP, Atkinson SR, Bataller R, Botwin G, Chalasani NP, Cordell HJ, Daly AK, Day CP, Eyer F, Foroud T, Gleeson D, Goldman D, Haber PS, Jacquet JM, Liang T, Liangpunsakul S, Masson S, Mathurin P, Moirand R, McQuillin A, Moreno C, Morgan MY, Mueller S, Müllhaupt B, Nagy LE, Nahon P, Nalpas B, Naveau S, Perney P, Pirmohamed M, Seitz HK, Soyka M, Stickel F, Thompson A, Thursz MR, Trépo E, Morgan TR, Seth D; GenomALC Consortium. Whitfield JB, et al. Among authors: daly ak. J Hepatol. 2022 Feb;76(2):275-282. doi: 10.1016/j.jhep.2021.10.005. Epub 2021 Oct 14. J Hepatol. 2022. PMID: 34656649 Free PMC article.

2

CYP2C9 polymorphism and warfarin dose requirements.

Daly AK, Day CP, Aithal GP. Daly AK, et al. Br J Clin Pharmacol. 2002 Apr;53(4):408-9. doi: 10.1046/j.1365-2125.2002.01572_6.x. Br J Clin Pharmacol. 2002. PMID: 11966680 Free PMC article. No abstract available.

3

Polymorphisms in immunoregulatory genes: towards individualized immunosuppressive therapy?

Daly AK, Day CP, Donaldson PT. Daly AK, et al. Am J Pharmacogenomics. 2002;2(1):13-23. doi: 10.2165/00129785-200202010-00002. Am J Pharmacogenomics. 2002. PMID: 12083951 Review.

4

Valine-alanine manganese superoxide dismutase polymorphism is not associated with alcohol-induced oxidative stress or liver fibrosis.

Stewart SF, Leathart JB, Chen Y, Daly AK, Rolla R, Vay D, Mottaran E, Vidali M, Albano E, Day CP. Stewart SF, et al. Among authors: daly ak. Hepatology. 2002 Dec;36(6):1355-60. doi: 10.1053/jhep.2002.36940. Hepatology. 2002. PMID: 12447859

5

Genetic and epigenetic factors in autoimmune reactions toward cytochrome P4502E1 in alcoholic liver disease.

Vidali M, Stewart SF, Rolla R, Daly AK, Chen Y, Mottaran E, Jones DE, Leathart JB, Day CP, Albano E. Vidali M, et al. Among authors: daly ak. Hepatology. 2003 Feb;37(2):410-9. doi: 10.1053/jhep.2003.50049. Hepatology. 2003. PMID: 12540792

6

Hepatic adducts, circulating antibodies, and cytokine polymorphisms in patients with diclofenac hepatotoxicity.

Aithal GP, Ramsay L, Daly AK, Sonchit N, Leathart JB, Alexander G, Kenna JG, Caldwell J, Day CP. Aithal GP, et al. Among authors: daly ak. Hepatology. 2004 May;39(5):1430-40. doi: 10.1002/hep.20205. Hepatology. 2004. PMID: 15122773

7

Genetic regulation of warfarin metabolism and response.

Daly AK, Aithal GP. Daly AK, et al. Semin Vasc Med. 2003 Aug;3(3):231-8. doi: 10.1055/s-2003-44458. Semin Vasc Med. 2003. PMID: 15199455 Review.

8

Upstream and coding region CYP2C9 polymorphisms: correlation with warfarin dose and metabolism.

King BP, Khan TI, Aithal GP, Kamali F, Daly AK. King BP, et al. Among authors: daly ak. Pharmacogenetics. 2004 Dec;14(12):813-22. doi: 10.1097/00008571-200412000-00004. Pharmacogenetics. 2004. PMID: 15608560

9

Genetic susceptibility to diclofenac-induced hepatotoxicity: contribution of UGT2B7, CYP2C8, and ABCC2 genotypes.

Daly AK, Aithal GP, Leathart JB, Swainsbury RA, Dang TS, Day CP. Daly AK, et al. Gastroenterology. 2007 Jan;132(1):272-81. doi: 10.1053/j.gastro.2006.11.023. Epub 2006 Nov 17. Gastroenterology. 2007. PMID: 17241877

10

HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin.

Daly AK, Donaldson PT, Bhatnagar P, Shen Y, Pe'er I, Floratos A, Daly MJ, Goldstein DB, John S, Nelson MR, Graham J, Park BK, Dillon JF, Bernal W, Cordell HJ, Pirmohamed M, Aithal GP, Day CP; DILIGEN Study; International SAE Consortium. Daly AK, et al. Among authors: daly mj. Nat Genet. 2009 Jul;41(7):816-9. doi: 10.1038/ng.379. Epub 2009 May 31. Nat Genet. 2009. PMID: 19483685

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

306 results

Search Page